| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| X Zhang, N Wang, A P Schachat, S Bao, M C Gillie. Glucocorticoids: structure, signaling and molecular mechanisms in the treatment of diabetic retinopathy and diabetic macular edema. Current molecular medicine. vol 14. issue 3. 2014-11-24. PMID:24467200. |
diabetic retinopathy (dr) is one of the leading causes of blindness in the working population worldwide. |
2014-11-24 |
2023-08-12 |
Not clear |
| Zh Z Khasanova, A N Samoĭlo. [Diabetic retinopathy in patients with type 1 diabetes mellitus]. Vestnik oftalmologii. vol 130. issue 2. 2014-11-21. PMID:24864506. |
thus, diabetic retinopathy (dr), a late nonspecific vascular complication of dm, is the leading cause of blindness in the working-age population. |
2014-11-21 |
2023-08-13 |
Not clear |
| Xiaoyi Gao, W James Gauderman, Paul Marjoram, Mina Torres, Yii-Der I Chen, Kent D Taylor, Jerome I Rotter, Rohit Varm. Native American ancestry is associated with severe diabetic retinopathy in Latinos. Investigative ophthalmology & visual science. vol 55. issue 9. 2014-11-18. PMID:25146985. |
diabetic retinopathy (dr) is a leading cause of blindness in working age adults. |
2014-11-18 |
2023-08-13 |
Not clear |
| Pavan Kumar Mishra, Abhijit Sinha, Kaveti Ravi Teja, Nitin Bhojwani, Sagar Sahu, Awanish Kuma. A computational modeling for the detection of diabetic retinopathy severity. Bioinformation. vol 10. issue 9. 2014-10-29. PMID:25352722. |
prolonged diabetes ultimately leads to diabetic retinopathy (dr) which is one of the leading causes of preventable blindness in the world. |
2014-10-29 |
2023-08-13 |
human |
| Sefika Burcak Polat, Nagihan Ugurlu, Fatma Yulek, Huseyin Simavli, Reyhan Ersoy, Bekir Cakir, Ozcan Ere. Evaluation of serum fibrinogen, plasminogen, α2-anti-plasmin, and plasminogen activator inhibitor levels (PAI) and their correlation with presence of retinopathy in patients with type 1 DM. Journal of diabetes research. vol 2014. 2014-10-28. PMID:24818165. |
diabetic retinopathy (dr) is the leading cause of blindness in the world. |
2014-10-28 |
2023-08-13 |
Not clear |
| Mohammad Shamsul Ola, Abdullah S Alhomid. Neurodegeneration in diabetic retina and its potential drug targets. Current neuropharmacology. vol 12. issue 4. 2014-10-24. PMID:25342945. |
diabetic retinopathy (dr) is one of the major complications of diabetes causing vision loss and blindness worldwide. |
2014-10-24 |
2023-08-13 |
Not clear |
| Marzieh Katibeh, Hossein Ziaei, Elnaz Panah, Hamid-Reza Moein, Sara Hosseini, Masumeh Kalantarion, Armen Eskandari, Mehdi Yaser. Knowledge and awareness of age related eye diseases: a population-based survey. Journal of ophthalmic & vision research. vol 9. issue 2. 2014-10-03. PMID:25279125. |
to determine general awareness and knowledge about cataracts, glaucoma and diabetic retinopathy (dr), as common avoidable causes of blindness in an iranian population. |
2014-10-03 |
2023-08-13 |
Not clear |
| Mina Elahy, Swati Baindur-Hudson, Vinicius F Cruzat, Philip Newsholme, Crispin R Das. Mechanisms of PEDF-mediated protection against reactive oxygen species damage in diabetic retinopathy and neuropathy. The Journal of endocrinology. vol 222. issue 3. 2014-09-30. PMID:24928938. |
oxidative stress plays an important role in the occurrence of diabetic retinopathy (dr), which is the major cause of blindness in young diabetic adults. |
2014-09-30 |
2023-08-13 |
Not clear |
| Menakshi Bhat, Mylène Pouliot, Réjean Couture, Elvire Vauche. The kallikrein-kinin system in diabetic retinopathy. Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques. vol 69. 2014-09-30. PMID:25130041. |
diabetic retinopathy (dr) is a major microvascular complication associated with type 1 and type 2 diabetes mellitus, which can lead to visual impairment and blindness. |
2014-09-30 |
2023-08-13 |
human |
| Bing-qing Zheng, Zhi Zhen. [Complement system and diabetic retinopathy]. [Zhonghua yan ke za zhi] Chinese journal of ophthalmology. vol 49. issue 7. 2014-09-11. PMID:24257364. |
it is well known that diabetic retinopathy (dr) is one of the common complications of diabetes mellitus and is the leading cause of blindness among working-age adults in the developed countries and regions, but the mechanism underlying its pathogenesis is not yet fully understood. |
2014-09-11 |
2023-08-12 |
Not clear |
| Gangaraju Rajashekhar, Ahmed Ramadan, Chandrika Abburi, Breedge Callaghan, Dmitry O Traktuev, Carmella Evans-Molina, Raj Maturi, Alon Harris, Timothy S Kern, Keith L Marc. Regenerative therapeutic potential of adipose stromal cells in early stage diabetic retinopathy. PloS one. vol 9. issue 1. 2014-09-10. PMID:24416262. |
diabetic retinopathy (dr) is the leading cause of blindness in working-age adults. |
2014-09-10 |
2023-08-12 |
human |
| Rita Mclauchla. Patient support to reduce risk diabetic retinopathy. Nursing times. vol 110. issue 25. 2014-08-20. PMID:25087401. |
diabetic retinopathy (dr) is the most common cause of blindness in the western world resulting in damage to the blood vessels of the retina. |
2014-08-20 |
2023-08-13 |
Not clear |
| Ales Maver, Dimitar Hristovski, Thomas C Rindflesch, Borut Peterli. Integration of data from omic studies with the literature-based discovery towards identification of novel treatments for neovascularization in diabetic retinopathy. BioMed research international. vol 2013. 2014-08-11. PMID:24350292. |
diabetic retinopathy (dr) is a secondary complication of diabetes associated with retinal neovascularization and represents the leading cause of blindness in the adult population in the developed world. |
2014-08-11 |
2023-08-12 |
Not clear |
| Ein Oh, Tae Keun Yoo, Eun-Cheol Par. Diabetic retinopathy risk prediction for fundus examination using sparse learning: a cross-sectional study. BMC medical informatics and decision making. vol 13. 2014-07-14. PMID:24033926. |
blindness due to diabetic retinopathy (dr) is the major disability in diabetic patients. |
2014-07-14 |
2023-08-12 |
Not clear |
| David S Boyer, J Jill Hopkins, Jonathan Sorof, Jason S Ehrlic. Anti-vascular endothelial growth factor therapy for diabetic macular edema. Therapeutic advances in endocrinology and metabolism. vol 4. issue 6. 2014-06-24. PMID:24324855. |
diabetic retinopathy (dr), which is the most common microvascular complication of diabetes, is the leading cause of new cases of blindness in working-aged adults. |
2014-06-24 |
2023-08-12 |
Not clear |
| Yousef H Aldebasi, Salah M Aly, Arshad H Rahman. Therapeutic implications of curcumin in the prevention of diabetic retinopathy via modulation of anti-oxidant activity and genetic pathways. International journal of physiology, pathophysiology and pharmacology. vol 5. issue 4. 2014-06-24. PMID:24379904. |
diabetic retinopathy (dr) is one of the most common complications of diabetes mellitus that affects the blood vessels of the retina, leading to blindness. |
2014-06-24 |
2023-08-12 |
Not clear |
| Gábor Márk Somfai, Erika Tátrai, Lenke Laurik, Boglárka Varga, Veronika Ölvedy, Hong Jiang, Jianhua Wang, William E Smiddy, Anikó Somogyi, Delia Cabrera DeBu. Automated classifiers for early detection and diagnosis of retinopathy in diabetic eyes. BMC bioinformatics. vol 15. 2014-06-17. PMID:24725911. |
dr is the leading cause of blindness in working-age adults in the developed world. |
2014-06-17 |
2023-08-13 |
Not clear |
| Angela Ka Wai Lai, Amy C Y L. Animal models of diabetic retinopathy: summary and comparison. Journal of diabetes research. vol 2013. 2014-06-16. PMID:24286086. |
diabetic retinopathy (dr) is a microvascular complication associated with chronic exposure to hyperglycemia and is a major cause of blindness worldwide. |
2014-06-16 |
2023-08-12 |
human |
| b' Snje\\xc5\\xbeana Ka\\xc5\\xa1telan, Martina Tomi\\xc4\\x87, Antonela Gverovi\\xc4\\x87 Antunica, Jasminka Salopek Rabati\\xc4\\x87, Spomenka Ljubi\\xc4\\x8. Inflammation and pharmacological treatment in diabetic retinopathy. Mediators of inflammation. vol 2013. 2014-06-05. PMID:24288441.' |
diabetic retinopathy (dr), the most common microvascular complication of diabetes mellitus, is estimated to be the leading cause of new blindness in the working population of developed countries. |
2014-06-05 |
2023-08-12 |
Not clear |
| Biao Yan, Zhi-Fu Tao, Xiu-Miao Li, Hui Zhang, Jin Yao, Qin Jian. Aberrant expression of long noncoding RNAs in early diabetic retinopathy. Investigative ophthalmology & visual science. vol 55. issue 2. 2014-04-14. PMID:24436191. |
diabetic retinopathy (dr) is one of the leading causes of blindness. |
2014-04-14 |
2023-08-12 |
human |